Page last updated: 2024-09-04

levofloxacin and Stevens-Johnson Syndrome

levofloxacin has been researched along with Stevens-Johnson Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barvaliya, M; Gajjar, K; Hirapara, H; Jaiswal, CS; Shah, H; Tripathi, CR	1
Bulut, T; Celik, B; Uzun, R; Yalcin, AD; Yalcin, AN	1
Davila, G; De Castro, F; Rojas, P; Ruiz-Hornillos, J; Zubeldia, JM	1
Pang, SM; Teo, WL	1
Christie, MJ; Sikaneta, TG; Tam, PY; Ting, RH; Wong, K	1
Islam, AF; Rahman, MS	1
Ackerman, BH; Cawley, MJ; Digwood-Lettieri, S; Guilday, RJ; Haith, LR; Patton, ML; Reilly, KJ	1

Reviews

1 review(s) available for levofloxacin and Stevens-Johnson Syndrome

Article	Year
Levofloxacin revisited. The Medical letter on drugs and therapeutics, 2011, Jul-11, Volume: 53, Issue:1368 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Stevens-Johnson Syndrome	2011

Other Studies

7 other study(ies) available for levofloxacin and Stevens-Johnson Syndrome

Article	Year
A Case Report of Antitubercular Drugs Induced Exanthematous Reaction Complicated by Acute Onset Levofloxacin Induced Toxic Epidermal Necrolysis (TEN). Current drug safety, 2018, Volume: 13, Issue:1 Topics: Acute Disease; Adult; Antitubercular Agents; Exanthema; Humans; Levofloxacin; Male; Stevens-Johnson Syndrome	2018
Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone. The American journal of case reports, 2016, Sep-16, Volume: 17 Topics: Aged; Anti-Allergic Agents; Anti-Bacterial Agents; Female; Glucocorticoids; Humans; Levofloxacin; Omalizumab; Prednisolone; Pulse Therapy, Drug; Stevens-Johnson Syndrome	2016
Toxic epidermal necrolysis induced by levofloxacin. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 102, Issue:5 Topics: Fatal Outcome; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pyelonephritis; Stevens-Johnson Syndrome	2009
Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin. Annals of the Academy of Medicine, Singapore, 2010, Volume: 39, Issue:8 Topics: Anti-Bacterial Agents; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Ofloxacin; Stevens-Johnson Syndrome	2010
Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Female; Humans; Levofloxacin; Ofloxacin; Seizures; Stevens-Johnson Syndrome	2005
Levofloxacin-induced fatal toxic epidermal necrolysis. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:6 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Fatal Outcome; Humans; Levofloxacin; Male; Ofloxacin; Stevens-Johnson Syndrome; Time Factors	2005
Levofloxacin-induced toxic epidermal necrolysis in an elderly patient. Pharmacotherapy, 2002, Volume: 22, Issue:6 Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Female; Fluid Therapy; Humans; Levofloxacin; Ofloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Skin; Stevens-Johnson Syndrome	2002